Tirzepatide is a dual-action agonist for GLP-1 and GIP receptors, intended solely for research use. Its robust receptor activity combination has demonstrated encouraging outcomes in studies focused on weight loss and metabolic health.
Offered in 10mg, 20mg, and 30mg doses, Tirzepatide presents an innovative solution for researchers investigating advanced methods for metabolic and weight loss interventions.
Key Benefits:
- For research purposes only
- Dual-action mechanism (GLP-1 and GIP) enhancing metabolic effects
- Available in 10mg, 20mg, and 30mg doses for versatile research
- Perfect for advanced studies on weight loss and metabolic health
- (includes free injection pen)
